|

Regional Cerebral Blood Flow and Metabolic Rate in Persistent Lyme Encephalopathy

ByTeam

Arch Gen Psychiatry. 2009;66(5):554-563. doi:10.1001/archgenpsychiatry.2009.29
May 2009, Vol 66, No. 5

Context: There is controversy regarding whether objective neurobiological abnormalities exist after intensive antibiotic treatment for Lyme disease.

Objectives: To determine whether patients with a history of well-characterized Lyme disease and persistent cognitive deficit show abnormalities in global or topographic distributions of regional cerebral blood flow (rCBF) or cerebral metabolic rate (rCMR).

Read full publication

Stay safe in the outdoors

Get a tick removal kit

Your support can change lives

Get our news and updates by email

Subscribe

Similar Posts

|

Highlights on molecular identification of closely related species.

ByTeam

Authors: Almeida LA, Araujo R Citation: Infect. Genet. Evol. 2012(Sep) Location: IPATIMUP, Institute of Molecular Pathology and Immunology, University of Porto;Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; ICBAS, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Rua de Jorge Viterbo Ferreira n.° 228, 4050-313 Porto, Portugal. Electronic address: almeida [dot] ligia [dot] mca…

| |

CanLyme Announces Grants for Physicians to Attend ILADS Virtual Scientific Conference

ByCanLyme Team

The Canadian Lyme Disease Foundation (CanLyme) is dedicated to promoting research, education, diagnosis and treatment of Lyme and associated diseases. CanLyme is offering a limited number of grants to practicing Canadian physicians to cover 80% of the registration fee for the International Lyme and Associated Diseases (ILADS) Annual Scientific Conference (including the Lyme Fundamentals program)…

| | | |

Bill C-442 is carried as is in Senate. Hear testimony in Canada’s Senate Committee on Bill C-442, An Act respecting a Federal Framework on Lyme Disease, as Bill moves forward.

ByTeam

Bill C-442 is carried in the Senate (signed into law with Royal assent Dec. 16th, 2014): Listen to testimony of ; December 3rd, 2014 Elizabeth May, MP  (begins after intro’s) Jim Wilson, CanLyme  (starts at 17:10 on time-bar) Dr. William Bowie, AMMI,  (starts at 17:17 on time-bar) After Dr. Bowie presents it is followed by…

| | | |

A review of ticks in Canada and health risks from exposure

ByCanLyme Team

Tick species are undergoing range expansions across Canada due to global warming, animal migration, and land fragmentation. It is estimated that their range is expanding northwards by 35–55km per year. Species posing the greatest risk to humans are the Ixodes scapularis (blacklegged tick) and the Ixodes pacificus (Western blacklegged tick). The risk of human tick-borne infections is increasing. Populations…

| | |

Breakthrough paves way for new Lyme disease treatment

ByCanLyme Team

published June 17th, 2019 A Virginia Tech biochemist has discovered the cellular component that contributes to Lyme arthritis, a debilitating and extremely painful condition that is the most common late stage symptom of Lyme disease, a press release said. According to the release from Virginia Tech, the biochemist, Brandon Jutras, found that as the Lyme-causing bacteria borrelia burgdorferi multiplies, it…

| | |

Popular on 630 CHED radio, the Ryan Jespersen show interviews CanLyme director Janet Sperling and Edmonton area support group founder Kim Spears

ByTeam

You can listen here at https://www.630ched.com/audio-vault/ Select May 25th, 9 am, then drag the scroll bar to 8:55 for the beginning of the Lyme talk.